Navigation Links
Jak3 in Medical News

Researchers identify new cell targets for preventing growth of breast and other tumors

...e proteins encoded by the candidate genes. They found that seven of the genes encoded membrane or secreted proteins. Four of these namely FAP, SFRP2, jak3 and SMPD3 had not just increased gene expression, but also increased protein expression in breast tumor vessels, and thus could be good targets for t...

St. Jude researchers find key step in programmed cell death

...e to keeping cells alive. For example, they demonstrated earlier that most cytokines controlling hematopoietic cells require an enzyme called Jak2, or jak3 in lymphocytes, at the receptors where cytokines attached to the cell. In screening for components that are regulated by the Jak enzymes, the St. J...

Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research

...vanced Phase 2 clinical studies for RA and ITP this year, and also a Phase 2 clinical study in systemic lupus erythematosus. In addition, Rigel's oral jak3 inhibitor, R348, is currently in a Phase 1 study for the potential treatment of psoriasis and RA. "Dan comes to Rigel with solid clinical research l...

New Technique Identifies Unknown Genetic Mutations That Can Cause Cancer

...samples later identified two more mutations in the jak3 gene. Thomas Mercher, a postdoctoral fellow ... a mouse model. "It was important to show that the jak3 mutation, when introduced in mice, would lead to a...leukemia-like illness. It did, confirming that the jak3 mutations play a central role in leukemia," said G...
Jak3 in Medical Technology

Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders

...8 in young, healthy males using a double blind, placebo controlled, single dose and multiple rising doses of R348. Results are expected in mid-2008. jak3 in RA and Other Immune Disorders RA affects approximately 1% of the population worldwide -- approximately 2.1 million Americans -- and is a debilita...

Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2

...es. XL019 is a potent JAK2 inhibitor (IC50 = 2 nM) with excellent selectivity versus the other members of the JAK kinase family (JAK1 IC50 = 130 nM, jak3 IC50 = 250 nM, TYK2 IC50 = 340 nM). It is active against both wild type and mutationally activated forms of JAK2, and in preclinical studies showed go...

Pharmacopeia Announces Third Quarter 2007 Financial Results

..., coupled with resources expended on the company's jak3 program. The expense for the jak3 program has been primarily classified as collabora...Prior to 2007, resources expended on the company's jak3 program were classified as proprietary research an...
Jak3 in Biological News

New strategy rapidly identifies cancer targets

...amples later identified two more mutations in the jak3 gene. Thomas Mercher, a postdoctoral fellow i...a mouse model. "It was important to show that the jak3 mutation, when introduced in mice, would lead to...eukemia-like illness. It did, confirming that the jak3 mutations play a central role in leukemia," said...
Jak3 in Biological Technology

Progen Shareholders Call Meeting to Spill Progen Board and Offer Merger or Full Cash Back to Shareholders

...considerable opportunity to unlock value in both stocks. "Cytopia is a world class drug development company with drug candidates ranging from the jak3 program partnered with global pharmaceutical company Novartis through to CYT997, a vascular disrupting agent which is now in Phase II clinical studies...

Rigel Announces Third Quarter 2008 Financial Results and Clinical Update

...igel plans to focus on psoriasis and possible topical applications with its jak3 inhibitor, R348, and to do so with a collaboration partner. Rigel will move...hibitor compound for transplant rejection. Rigel expects to select this new jak3 inhibitor compound by the end of 2008. Rigel will proceed on its own with t...

GlaxoSmithKline and Cellzome Announce Major Strategic Alliance

...logy to the discovery and development of innovative small-molecule kinase inhibitors targeting key inflammatory mediators such as PI3Kg and d, Zap-70, jak3 and mTOR, as potential oral therapeutics for rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, psoriasis and asthma. In addition...
Other Tags
(Date:9/17/2014)... Historically, spaceflight has been reserved for the very ... meet the highest physical and psychological standards to ... the advent of commercial spaceflight, average people can ... has had very little information about what medical ... in the spaceflight environment, as most medical conditions ...
(Date:9/17/2014)... People who struggle to distinguish between a business strategy and ... get the answer by reading Per Wickstrom’s latest blog post. ... business plan and a business strategy are both strategic – ... way I view it is that a business plan is ... two.” , According to the blog post, a business ...
(Date:9/17/2014)... manipulation these sound like the ideas of ... are components of an exciting new approach to ... models of metastatic prostate cancer, scientists at Virginia ... Molecular Medicine and Johns Hopkins Medical Institutions have ... that could revolutionize doctors, ability to see tumors ...
(Date:9/17/2014)... N.J. (PRWEB) September 17, 2014 ... advanced delivery technologies and development solutions for drugs, ... launch of OptiPact™, an integrated service and technology ... compaction, and provided from the company’s 450,000 sq. ... describes Catalent’s ability to integrate optimal formulation, development, ...
(Date:9/17/2014)... WEDNESDAY, Sept. 17, 2014 (HealthDay News) -- Positive messages ... some people kick the habit, a new study suggests. ... responded better to "loss-framed" messages about the harmful effects ... quit whenever they want benefit more from "gain-framed," or ... The researchers concluded that using a mix of ...
Breaking Medicine News(10 mins):Health News:Space: The final frontier… open to the public 2Health News:Per Wickstrom’s Latest Blog Explores the Difference Between a Business Plan and a Business Strategy 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 3Health News:New OptiPact™ Technology Introduced by Catalent 2Health News:More Than One Kind of Message May Convince Smokers to Quit, Study Says 2
(Date:9/16/2014)... have discovered the "molecular brakes" that time the generation ... mice. These "hair cells" translate sound waves into electrical ... interpreted as sounds. If the arrangement of the cells ... of the research will be published in The ... proteins Hey1 and Hey2 act as brakes to prevent ...
(Date:9/16/2014)... inherit certain traits from our parents that are pre-determined. ... play out by taking certain drugs or better yet, ... team of researchers at the Boston University School of ... research. , Epigenetics regulates gene expression in a ... which prevent permanent mutations or alterations within the gene ...
(Date:9/16/2014)... species has its own bacterial identity. That,s the conclusion ... institutions who studied the genetic fingerprints of bacteria on ... , "This study demonstrates for the first time that ... ecological strategies possess very different microbial communities on their ... postdoctoral researcher in the UO,s Institute of Ecology and ...
Breaking Biology News(10 mins):Hey1 and Hey2 ensure inner ear 'hair cells' are made at the right time, in the right place 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 3Microbiome research shows each tree species has a unique bacterial identity 2
Other Contents